Are long-term bisphosphonate users a reality?: Dose years for current bisphosphonate users assessed using the danish national prescription database

B Abrahamsen

doi:10.1007/s00198-012-1994-x

Are long-term bisphosphonate users a reality? Dose years for current bisphosphonate users assessed using the danish national prescription database

B Abrahamsen

11 Citationer (Scopus)

Abstract

The prevalence of long-term bisphosphonate use may be low due to low refill compliance and gaps in treatment. An analysis of the prescription history of 58,674 bisphosphonate users in Denmark found that only 2.8 % had received ten dose years of treatment or above.

Originalsprog	Engelsk
Tidsskrift	Osteoporosis International
Vol/bind	24
Udgave nummer	1
Sider (fra-til)	369-72
Antal sider	4
ISSN	0937-941X
DOI	https://doi.org/10.1007/s00198-012-1994-x
Status	Udgivet - 2013

Adgang til dokumentet

10.1007/s00198-012-1994-x

Citationsformater

@article{f382e06b754f448693c26cdb49502255,

title = "Are long-term bisphosphonate users a reality?: Dose years for current bisphosphonate users assessed using the danish national prescription database",

abstract = "The prevalence of long-term bisphosphonate use may be low due to low refill compliance and gaps in treatment. An analysis of the prescription history of 58,674 bisphosphonate users in Denmark found that only 2.8 % had received ten dose years of treatment or above.",

author = "B Abrahamsen",

year = "2013",

doi = "10.1007/s00198-012-1994-x",

language = "English",

volume = "24",

pages = "369--72",

journal = "Osteoporosis International",

issn = "0937-941X",

publisher = "Springer U K",

number = "1",

}

TY - JOUR

T1 - Are long-term bisphosphonate users a reality?

T2 - Dose years for current bisphosphonate users assessed using the danish national prescription database

AU - Abrahamsen, B

PY - 2013

Y1 - 2013

N2 - The prevalence of long-term bisphosphonate use may be low due to low refill compliance and gaps in treatment. An analysis of the prescription history of 58,674 bisphosphonate users in Denmark found that only 2.8 % had received ten dose years of treatment or above.

AB - The prevalence of long-term bisphosphonate use may be low due to low refill compliance and gaps in treatment. An analysis of the prescription history of 58,674 bisphosphonate users in Denmark found that only 2.8 % had received ten dose years of treatment or above.

U2 - 10.1007/s00198-012-1994-x

DO - 10.1007/s00198-012-1994-x

M3 - Journal article

C2 - 22572963

SN - 0937-941X

VL - 24

SP - 369

EP - 372

JO - Osteoporosis International

JF - Osteoporosis International

IS - 1

ER -

Are long-term bisphosphonate users a reality? Dose years for current bisphosphonate users assessed using the danish national prescription database

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater